Infoscience

Journal article

Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial—VIP report no. 1

    Note:

    Verteporfin in Photodynamic Therapy (VIP) Study Group

    Reference

    • EPFL-ARTICLE-162981

    Record created on 2011-02-01, modified on 2016-08-09

Fulltext

  • There is no available fulltext. Please contact the lab or the authors.

Related material